Skip to content
TrustList
Rose Park Advisors logo
Venture capital firm

Rose Park Advisors

A US investment firm that applies the theory of disruptive innovation to its investment decisions

Rose Park Advisors cover

About Rose Park Advisors

Rose Park Advisors, LLC is an investment firm founded with co-founder Clay Christensen, the Harvard Business School professor known for his work on disruptive innovation. The firm draws on frameworks from that research, aiming to understand why established companies succeed or fail and when new market entrants are likely to gain ground. It describes its approach as applying academically derived frameworks in a similar way to how physical theories explain natural systems, using them to assess the likely direction of businesses and markets. The firm was an early investor in BioLite, a company operating in previously un-electrified parts of Africa, and has continued as a capital and strategic partner to that business. Rose Park's activities include supporting portfolio companies and entrepreneurs alongside its investment decisions.

Profile written by TrustList from the business's own published information, Sep 2026.

Categories & features

Ask TrustList to introduce you to Rose Park Advisors

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Rose Park Advisors

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Rose Park Advisors.

Rose Park Advisors alternatives

Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

An angel investment group of University of Pennsylvania alumni backing early-stage technology start-ups

Open-source blockchain with its own digital currency, digital assets, smart contracts and secure authentication

Life science investor putting money into young oncology and genetic disease drug developers